Schedule 13G ownership disclosure

NEXTCURE INC

Common Stock par value $0.001 per share · CUSIP: 65343E108

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Pfizer Inc. (IRS Identification No.: 13-5315170)

    Shares: 157,646.00 · Class: 3.0%

  • Pfizer Ventures (US) LLC (IRS Indentification No. 82-5524518 )

    Shares: 131,109.00 · Class: 2.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000078003-26-000018
Form type
SCHEDULE 13G/A
Filer
NextCure, Inc.
CIK
CIK 1661059
Filed
Feb 13, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub